Ireland : Allergan Announces Positive Topline Phase 3 Clinical Data for Bimatoprost SR (Sustained-Release) Implant for IOP Lowering in Patients with Open-Angle Glaucoma or Ocular Hypertension

Source :: Mena Report. June 14, 2018
Publication Year :: 2018
Abstract: Allergan plc, a leading global pharmaceutical company, today announced the release of new topline clinical trial data on Bimatoprost SR, the first-in-class sustained-release, biodegradable implant for the reduction of intraocular [...]

Subjects :: Allergan PLC -- Product development
Clinical trials
Ophthalmic agents -- Product development
Hypertension -- Care and treatment
Pharmaceutical industry -- Product development
Open-angle glaucoma -- Care and treatment
Business, international

Tools